Clinical Trials Logo

Clinical Trial Summary

The overall aim of the study is:

To provide accurate and reliable information regarding NSCLC clinical management across MENA region in order to detect unmet medical needs of this disease in terms of:

- Patient and hospital characteristics.

- Diagnostic and treatment approaches: initial and subsequent.

- Follow-up patterns in clinical management.

- Outcomes: symptoms, death, functionality, quality of life.

- Use of resources and burden on patients and health care systems.


Clinical Trial Description

Epidemiological study to describe NSCLC clinical management patterns in MENA ;


Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01562665
Study type Observational
Source AstraZeneca
Contact
Status Completed
Phase N/A
Start date June 2012
Completion date February 2015

See also
  Status Clinical Trial Phase
Recruiting NCT02821949 - Evaluation of Serum Procalcitonin Rate in Patients With Stage IV Non-small Cell Lung Cancer in First Line Chemotherapy N/A